Antimicrobial Agents and Chemotherapy · 2007 · 78 citations · 10 references
MedicineMicrobiologyPharmacologyAntimicrobial PharmacologyChemotherapyDrug DiscoveryAntibacterial AgentsAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntibacterial Drug DevelopmentBactericidal AgentsMycobacterial DiseaseNovel Antibacterial Drug DiscoveryPostantibiotic EffectSynergistic Inhibitor Effects
Translocase I inhibitor compounds derived from capuramycin demonstrated rapid bactericidal activity against several different mycobacterial species. SQ641 was the most active of the compounds, with a MIC of 0.12 to 8 microg/ml, a postantibiotic effect of 55 h, and interesting synergistic effects with other antitubercular drugs.
10
Tetsufumi Koga, Takashi Fukuoka, Norio Doi et al. · Journal of Antimicrobial Chemotherapy · 2004 · 86 citations · Full text